bull trade occurring with tech development on certain chip development, recent studies insuring the markets favour towards a break through
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.55 EUR
30.33 M EUR
506.03 M EUR
46.37 M
About Core Laboratories Inc.
Sector
Industry
CEO
Lawrence V. Bruno
Website
Headquarters
Houston
Founded
2012
FIGI
BBG01GHX8HN1
Core Laboratories Inc. provides proprietary and patented reservoir description and production enhancement services. It operates through the Reservoir Description and Production Enhancement segments. The Reservoir Description segment engages in petroleum reservoir analysis for energy. The Production Enhancement segment includes services and manufactured products associated with reservoir well completions, perforations, stimulation, production and well abandonment. The company was founded in 1936 and is headquartered in Houston, TX.
Related stocks
$CLB Nice rip coming out of accumulationCLB core labs is ripping out of an accumulation pattern and above strong resistance at the 32 zone.
I like it long above 32 , already up 9% on the day, will continue to add on dips.
CLBCore Laboratories N.V. (NYSE:CLB) looking primed for a range break to the upside. Breakout watch over 30.5
Core Laboratories massive run up after price calloutReally loving how this played off my last update, going to keep watching, however I locked in profits at this level i continued about 25% of the position// I AM NOT a financial advisor nor am i suggesting to anyone that they take any action this is for entertainment purposes only//
My prediction i
CLB Currently owned at 93% of all outstanding shares by institutional investors and 1.1% of insider investors own shares.
Gross revenue: 668 Million
Price/Sales: 1.93
Net income: +101.98 Million
Earnings per share: $1.79
Price/Earnings: 15.54
Net Margins: -19
% Return on equity: 45
% Return on assets:
CLB - Possible 30% BreakoutCLB has been running into strong resistance at around the $36.30 level since mid-Jan. However, there is darn near zero historical resistance between that and the $47.30 level, and decent reason to believe the current resistance will be broken in the coming weeks.
For the past couple of weeks, price
CORE LABORATORIES NV - LONGNYSE:CLB
While indicators and analysts are advising to short it, I'll go to long above $10.8.
CLB - Possible Bear Flag formation short setupCLB - small money 55% sale in march - Target 27.23. Possible Bear Flag. Possible short below 59.87. Stop signal 67.23
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CORE LABORATORIES stocks are traded under the ticker HJ1.
We've gathered analysts' opinions on CORE LABORATORIES future price: according to them, HJ1 price has a max estimate of 15.59 EUR and a min estimate of 8.66 EUR. Watch HJ1 chart and read a more detailed CORE LABORATORIES stock forecast: see what analysts think of CORE LABORATORIES and suggest that you do with its stocks.
Yes, you can track CORE LABORATORIES financials in yearly and quarterly reports right on TradingView.
CORE LABORATORIES is going to release the next earnings report on Oct 22, 2025. Keep track of upcoming events with our Earnings Calendar.
HJ1 earnings for the last quarter are 0.16 EUR per share, whereas the estimation was 0.16 EUR resulting in a 1.94% surprise. The estimated earnings for the next quarter are 0.18 EUR per share. See more details about CORE LABORATORIES earnings.
CORE LABORATORIES revenue for the last quarter amounts to 110.49 M EUR, despite the estimated figure of 109.62 M EUR. In the next quarter, revenue is expected to reach 113.10 M EUR.
HJ1 net income for the last quarter is 9.03 M EUR, while the quarter before that showed −142.35 K EUR of net income which accounts for 6.44 K% change. Track more CORE LABORATORIES financial stats to get the full picture.
Yes, HJ1 dividends are paid quarterly. The last dividend per share was 0.01 EUR. As of today, Dividend Yield (TTM)% is 0.38%. Tracking CORE LABORATORIES dividends might help you take more informed decisions.
CORE LABORATORIES dividend yield was 0.23% in 2024, and payout ratio reached 5.97%. The year before the numbers were 0.23% and 5.09% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 6, 2025, the company has 3.5 K employees. See our rating of the largest employees — is CORE LABORATORIES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CORE LABORATORIES EBITDA is 50.40 M EUR, and current EBITDA margin is 12.13%. See more stats in CORE LABORATORIES financial statements.
Like other stocks, HJ1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CORE LABORATORIES stock right from TradingView charts — choose your broker and connect to your account.